The DOI matches its Crossref record; 120 of the 123 references it cites were found in a registry or an index.
Cortical inhibitory neurons and schizophrenia
Abstract
Impairments in certain cognitive functions, such as working memory, are core features of schizophrenia. Convergent findings indicate that a deficiency in signalling through the TrkB neurotrophin receptor leads to reduced GABA (gamma-aminobutyric acid) synthesis in the parvalbumin-containing subpopulation of inhibitory GABA neurons in the dorsolateral prefrontal cortex of individuals with schizophrenia. Despite both pre- and postsynaptic compensatory responses, the resulting alteration in perisomatic inhibition of pyramidal neurons contributes to a diminished capacity for the gamma-frequency synchronized neuronal activity that is required for working memory function. These findings reveal specific targets for therapeutic interventions to improve cognitive function in individuals with schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced expression of GAD67, the main GABA-synthesizing enzyme in the brain, appears to contribute to altered interneuron activity in psychosis [86,87] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [86]
In the citing paper
“Certain classes of GABA interneurons are altered in individuals with psychosis, in particular reduced density in the anterior cingulate and reduced activity in the dorsolateral prefrontal cortex in the subpopulation expressing parvalbumin [84-86] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [86]
In the citing paper
“Thus, the correct balance of inhibition and excitation seems to be critical for normative executive function, and conversely, disturbance of this balance is thought to be a fundamental component of psychiatric illness.69, 70”
From A role for synaptic plasticity in the adolescent development of executive function (2013) · cites this paper as [69]
In the citing paper
“Moreover, the expression of several GABA receptors and markers of inhibitory synapses are also altered in schizophrenia 50 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [50]
In the citing paper
“Schizophrenia is increasingly recognized as a neurodevelopmental disorder that involves alterations in brain circuits, including dysfunction of parvalbumin (PV)-positive, fast-spiking GABA neurons (1, 2).”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [1]
In the citing paper
“its onset is linked to a potential disruption of the physiological maturation of inhibitory neural networks consisting of fast-spiking parvalbumin-positive gamma-aminobutric acid (GABAergic) interneurons”
From Perineuronal nets and schizophrenia: The importance of neuronal coatings (2014) · cites this paper as Lewis et al., 2005
In the citing paper
“Dysfunction and/or deficient inhibitory output from PV interneurons may be a common mechanism of multiple psychiatric disorders, such as schizophrenia (SCZ) (Lewis et al. 2005), autism spectrum disorders (ASD) (Gao and Penzes 2015) and bipolar disorder (BD) (Ruden et al. 2021).”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Lewis et al. 2005
In the citing paper
“Specifically, there is growing support for a hypothesis that cortical disinhibition occurs in schizophrenia, due to the disrupted functioning of inhibitory interneurons, which results in elevated E/I ratio (Lewis et al. 2005;Marin 2012).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“The prefrontal cortex is a key node in the distributed cortical network recruited during WM (Owen et al. 2005;Fuster 2008) and exhibits altered inhibitory microcircuitry in schizophrenia (Lewis et al. 2005;Bitanihirwe et al. 2009).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“Elevated prefrontal E/I ratio may result from alterations in multiple pathways that are implicated in schizophrenia.These include GABAergic deficits, such as reduced GAD67 production (Lewis et al. 2005); increased background input from other areas such as the thalamus or hippocampus (Lisman et al. 2008); or abnormal levels of neuromodulators (Laruelle et al. 2003).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
In the citing paper
“Both interneuron cell classes are altered in schizophrenia (Lewis et al. 2005;Morris et al. 2008;Bitanihirwe et al. 2009).”
From Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model (2014) · cites this paper as Lewis et al. 2005
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
Principles of Frontal Lobe Function
Stuss, D. T. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,731
Topography Of Cognition: Parallel Distributed Networks In Primate Association Cortex
Goldman‐Rakic, P. S. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.001033 · Cited by 1,658
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Self-citationSynchronization of neuronal activity in hippocampus by individual GABAergic interneurons
Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O., & Somogyi, P. (1995) · Nature · doi:10.1038/378075a0 · Cited by 1,498
Flagged first, then by citations
3 of the 123 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Konopaske, G. T., Sweet, R. A. & Lewis, D. A. GABA transporter-1 immunoreactivity in auditory association cortex in schizophrenia. Soc. Neurosci. Abstr. 34, 110.11 (2004).
- Peters, A. in Cerebral Cortex Vol. 1 (eds Jones, E. G. & Peters, A.) 361–380 (Plenum, New York, 1984).
Cited by
Sorted by citations
Items 201–300 of 1,012
Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
Govindpani, K., Calvo-Flores Guzmán, B., Vinnakota, C., Waldvogel, H., Faull, R., & Kwakowsky, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081813 · Cited by 208
Optogenetic dissection of medial prefrontal cortex circuitry
Riga, D., Matos, M. R., Glas, A., Smit, A. B., Spijker, S., & Van den Oever, M. C. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00230 · Cited by 208
Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders
Selten, M. M., van Bokhoven, H., & Kasri, N. N. (2018) · F1000Research · doi:10.12688/f1000research.12155.1 · Cited by 221
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Interplay between DISC1 and GABA Signaling Regulates Neurogenesis in Mice and Risk for Schizophrenia
Kim, J., Liu, C. Y., Zhang, F., Duan, X., Wen, Z., Song, J., Feighery, E. L., Lu, B., Rujescu, D., Clair, D. S., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.037 · Cited by 212
Excitation control: balancing PSD-95 function at the synapse
Keith, D. J. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.004.2008 · Cited by 223
Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003889 · Cited by 205
Damaj, L., Lupien‐Meilleur, A., Lortie, A., Riou, É., Ospina, L. H., Gagnon, L., Vanasse, C., & Rossignol, E. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.21 · Cited by 206
EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood
Robertson, M. M., Furlong, S., Voytek, B., Donoghue, T., Boettiger, C. A., & Sheridan, M. A. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00388.2019 · Cited by 205
Gandal, M. J., Sisti, J., Klook, K., Ortinski, P. I., Leitman, V, Liang, Y., Thieu, T., Anderson, R., Pierce, R. C., Jonak, G., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.69 · Cited by 204
Molecular profiles of schizophrenia in the CNS at different stages of illness
Narayan, S., Tang, B., Head, S. R., Gilmartin, T. J., Sutcliffe, J. G., Dean, B., & Thomas, E. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.023 · Cited by 207
The Roles of PDGF in Development and During Neurogenesis in the Normal and Diseased Nervous System
Funa, K., & Sasahara, M. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9479-z · Cited by 212
Dendritic Mechanisms Underlying Rapid Synaptic Activation of Fast-Spiking Hippocampal Interneurons
Hu, H., Martina, M., & Jonas, P. (2010) · Science · doi:10.1126/science.1177876 · Cited by 202
Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202
Satta, R., Maloku, E., Zhubi, A., Pibiri, F., Hajós, M., Costa, E., & Guidotti, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808699105 · Cited by 202
The polygenic architecture of schizophrenia — rethinking pathogenesis and nosology
Smeland, O. B., Frei, O., Dale, A. M., & Andreassen, O. A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0364-0 · Cited by 214
Pyramidal Neurons in Prefrontal Cortex Receive Subtype-Specific Forms of Excitation and Inhibition
Lee, A. T., Gee, S. M., Vogt, D., Patel, T., Rubenstein, J. L., & Sohal, V. S. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.031 · Cited by 201
Canetta, S., Bolkan, S., Padilla-Coreano, N., Song, L. J., Sahn, R., Harrison, N. L., Gordon, J. A., Brown, A., & Kellendonk, C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.222 · Cited by 201
Circular inferences in schizophrenia
Jardri, R., & Denève, S. (2013) · Brain · doi:10.1093/brain/awt257 · Cited by 201
Yee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201
Puig, M. V., Watakabe, A., Ushimaru, M., Yamamori, T., & Kawaguchi, Y. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3335-09.2010 · Cited by 205
GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system
Fritschy, J., & Panzanelli, P. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12534 · Cited by 212
Uhlhaas, P. J., Pipa, G., Neuenschwander, S., Wibral, M., & Singer, W. (2010) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2010.10.004 · Cited by 206
The Neurobiology of Cognition in Schizophrenia
Tamminga, C. A. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0906e11 · Cited by 200
Cell Type-Specific Development of NMDA Receptors in the Interneurons of Rat Prefrontal Cortex
Wang, H.-X., & Gao, W. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.20 · Cited by 201
Dong, E., Agís‐Balboa, R. C., Simonini, M. V., Grayson, D. R., Costa, E., & Guidotti, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505394102 · Cited by 199
Inhibitory Synapses Are Repeatedly Assembled and Removed at Persistent Sites In Vivo
Villa, K. L., Berry, K., Subramanian, J., Cha, J. W., Oh, W. C., Kwon, H., Kubota, Y., So, P. T. C., & Nedivi, E. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.010 · Cited by 208
The role of BDNF in the pathophysiology and treatment of schizophrenia
Favalli, G. P. D. S., Li, J., Belmonte-de-Abreu, P. S., Wong, A. H. C., & Daskalakis, Z. J. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.022 · Cited by 207
GABAAReceptors in Central Nervous System Disease: Anxiety, Epilepsy, and Insomnia
Möhler, H. (2006) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890600920035 · Cited by 196
The Howling Cortex: Seizures and General Anesthetic Drugs
Voss, L. J., Sleigh, J. W., Barnard, J. P. M., & Kirsch, H. E. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181852595 · Cited by 194
Marx, C. E., Keefe, R. S. E., Buchanan, R. W., Hamer, R. M., Kilts, J. D., Bradford, D. W., Strauss, J. L., Naylor, J. C., Payne, V. M., Lieberman, J. A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.26 · Cited by 193
Vierling-Claassen, D., Siekmeier, P. J., Stufflebeam, S. M., & Kopell, N. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00870.2007 · Cited by 200
Development of the GABAergic System from Birth to Adolescence
Kilb, W. (2012) · The Neuroscientist · doi:10.1177/1073858411422114 · Cited by 190
Adenosine hypothesis of schizophrenia – Opportunities for pharmacotherapy
Boison, D., Singer, P., Shen, H., Feldon, J., & Yee, B. K. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.048 · Cited by 194
A Review of Disrupted-in-Schizophrenia-1 (disc1): Neurodevelopment, Cognition, and Mental Conditions
Ishizuka, K., Paek, M., Kamiya, A., & Sawa, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.065 · Cited by 190
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
Pratt, J. A., Winchester, C. L., Dawson, N., & MORRIS, B. J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3649 · Cited by 199
Bissonette, G. B., Powell, E. M., & Roesch, M. R. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.037 · Cited by 207
Dong, E., Guidotti, A., Grayson, D. R., & Costa, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700529104 · Cited by 194
Generation of interneuron diversity in the mouse cerebral cortex
Gelman, D. M., & Marín, O. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07267.x · Cited by 188
Cunningham, M. O., Hunt, J., Middleton, S. J., LeBeau, F. E. N., Gillies, M. J., Davies, C. H., Maycox, P. R., Whittington, M. A., & Racca, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5054-05.2006 · Cited by 190
Ruzicka, W. B., Zhubi, A., Veldić, M., Grayson, D. R., Costa, E., & Guidotti, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001954 · Cited by 187
Hillard, C. J., Weinlander, K. M., & Stuhr, K. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.020 · Cited by 190
Wnt Signaling: Role in Alzheimer Disease and Schizophrenia
Inestrosa, N. C., Montecinos-Oliva, C., & Fuenzalida, M. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9417-5 · Cited by 192
Interneurons from Embryonic Development to Cell-Based Therapy
Southwell, D. G., Nicholas, C. R., Basbaum, A. I., Stryker, M. P., Kriegstein, A. R., Rubenstein, J. L. R., & Álvarez-Buylla, A. (2014) · Science · doi:10.1126/science.1240622 · Cited by 187
Thompson, M., Weickert, C. S., Wyatt, E. J., & Webster, M. J. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.02.005 · Cited by 193
GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies
de Jonge, J. C., Vinkers, C. H., Pol, H. E. H., & Marsman, A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00118 · Cited by 203
Inda, M. C., DeFelipe, J., & Muñoz, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511197103 · Cited by 192
Hierarchical Organization of Gamma and Theta Oscillatory Dynamics in Schizophrenia
Kirihara, K., Rissling, A. J., Swerdlow, N. R., BRAFF, D. L., & Light, G. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.016 · Cited by 184
Genetics and Function of Neocortical GABAergic Interneurons in Neurodevelopmental Disorders
Rossignol, E. (2011) · Neural Plasticity · doi:10.1155/2011/649325 · Cited by 192
Premoli, I., Rivolta, D., Espenhahn, S., Castellanos, N. P., Belardinelli, P., Ziemann, U., & Müller‐Dahlhaus, F. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.09.028 · Cited by 182
Sensory-Evoked Gamma Oscillations in Chronic Schizophrenia
Spencer, K. M., Niznikiewicz, M. A., Shenton, M. E., & McCarley, R. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.017 · Cited by 182
Extracellular matrix abnormalities in schizophrenia
Berretta, S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.010 · Cited by 179
The many faces of nitric oxide in schizophrenia. A review
Bernstein, H., Bogerts, B., & Keilhoff, G. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.05.019 · Cited by 179
Rosenfeld, A. J., Lieberman, J. A., & Jarskog, L. F. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq015 · Cited by 178
Swerdlow, N. R., BRAFF, D. L., & Geyer, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116661075 · Cited by 186
Epigenetics and the Biological Basis of Gene × Environment Interactions
Bagot, R. C., & Meaney, M. J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.001 · Cited by 177
The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology
Homberg, J. R., Molteni, R., Calabrese, F., & Riva, M. A. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.012 · Cited by 177
Developmental Perspectives on Oxytocin and Vasopressin
Hammock, E. A. D. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.120 · Cited by 184
Traumatic Brain Injury Detection Using Electrophysiological Methods
Rapp, P. E., Keyser, D. O., Albano, A. M., Hernandez, R. S., Gibson, D. B., Zambon, R. A., Hairston, W. D., Hughes, J., Krystal, A. D., & Nichols, A. S. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00011 · Cited by 184
Fragile X Syndrome: The GABAergic System and Circuit Dysfunction
Paluszkiewicz, S. M., Martin, B. S., & Huntsman, M. M. (2011) · Developmental Neuroscience · doi:10.1159/000329420 · Cited by 185
Trippe, J., Mix, A., Aydın-Abidin, S., Funke, K., & Benali, A. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1961-8 · Cited by 185
Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk
Barron, H., Hafizi, S., Andreazza, A. C., & Mizrahi, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030651 · Cited by 183
Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175
Sun, Q., Li, X., Ren, M., Zhao, M., Zhong, Q., Ren, Y., Luo, P., Ni, H., Zhang, X., Zhang, C., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0429-9 · Cited by 180
Shamir, A., Kwon, O., Karavanova, I. D., Vullhorst, D., Leiva‐Salcedo, E., Janssen, M. J., & Buonanno, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1899-11.2012 · Cited by 176
Nawa, H., & Takei, N. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.06.002 · Cited by 179
Meechan, D. W., Tucker, E. S., Maynard, T. M., & LaMantia, A.-S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905696106 · Cited by 173
Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.014 · Cited by 173
Modulation of cortical inhibition by rTMS – findings obtained from animal models
Funke, K., & Benali, A. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.206573 · Cited by 173
Buchanan, R. W., Keefe, R. S. E., Lieberman, J. A., Barch, D. M., Csernansky, J. G., Goff, D. C., Gold, J. M., Green, M. F., Jarskog, L. F., Javitt, D. C., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.052 · Cited by 172
The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits
Buonanno, A. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.07.012 · Cited by 173
Common Origins of Hippocampal Ivy and Nitric Oxide Synthase Expressing Neurogliaform Cells
Tricoire, L., Pelkey, K. A., Daw, M. I., Sousa, V. H., Miyoshi, G., Jeffries, B., Cauli, B., Fishell, G., & McBain, C. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5123-09.2010 · Cited by 171
Individual Differences in Subconscious Motor Control Predicted by GABA Concentration in SMA
Boy, F., Evans, J., Edden, R. A. E., Singh, K. D., Husain, M., & Sumner, P. (2010) · Current Biology · doi:10.1016/j.cub.2010.09.003 · Cited by 179
Duncan, C. E., Webster, M. J., Rothmond, D. A., Bahn, S., Elashoff, M., & Shannon Weickert, C. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.12.007 · Cited by 169
Farzan, F., Barr, M. S., LEVINSON, A. J., Chen, R. E., Wong, W., Fitzgerald, P. B., & Daskalakis, Z. J. (2010) · Brain · doi:10.1093/brain/awq046 · Cited by 170
The contribution of GABAergic dysfunction to neurodevelopmental disorders
Ramamoorthi, K., & Lin, Y. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.003 · Cited by 173
Cellular Patterns of Transcription Factor Expression in Developing Cortical Interneurons
Cobos, I., Long, J. E., Thwin, M. T., & Rubenstein, J. L. R. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhk003 · Cited by 167
Kargieman, L., Santana, N., Mengod, G., Celada, P., & Artigas, F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704848104 · Cited by 166
Leiser, S., Bowlby, M., Comery, T., & Dunlop, J. (2009) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2009.03.009 · Cited by 167
Senkowski, D., & Gallinat, J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.034 · Cited by 179
McGarry, L. M. (2010) · Frontiers in Neural Circuits · doi:10.3389/fncir.2010.00012 · Cited by 166
Long-range synchrony of gamma oscillations and auditory hallucination symptoms in schizophrenia
Mulert, C., Kirsch, V., Pascual-Marqui, R., McCarley, R. W., & Spencer, K. M. (2011) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2010.08.004 · Cited by 165
What We Know: Findings That Every Theory of Schizophrenia Should Explain
MacDonald, A. W., & Schulz, S. C. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp017 · Cited by 171
Murray, A., Wołoszynowska-Fraser, M. U., Ansel-Bollepalli, L., Marshall-Phelps, K. L., Foggetti, A., Crouch, B., Riedel, G., & Wulff, P. (2015) · Scientific Reports · doi:10.1038/srep16778 · Cited by 173
Downregulation of Parvalbumin at Cortical GABA Synapses Reduces Network Gamma Oscillatory Activity
Volman, V., Behrens, M. M., & Sejnowski, T. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3041-11.2011 · Cited by 164
A Dynamical Systems Hypothesis of Schizophrenia
Loh, M., Rolls, E. T., & Deco, G. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030228 · Cited by 164
Powell, S. B., Sejnowski, T. J., & Behrens, M. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.049 · Cited by 164
Amyotrophic lateral sclerosis: a long preclinical period?
Eisen, A., Kiernan, M. C., Mitsumoto, H., & Swash, M. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307135 · Cited by 167
Reduced Natural Oscillatory Frequency of Frontal Thalamocortical Circuits in Schizophrenia
Ferrarelli, F., Sarasso, S., Bodien, Y. G., Riedner, B. A., Peterson, M. J., Bellesi, M., Massimini, M., Postle, B. R., & Tononi, G. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.147 · Cited by 163
Roopun, A. K., Cunningham, M. O., Racca, C., Alter, K., Traub, R. D., & Whittington, M. A. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn059 · Cited by 165
More GABA, less distraction: a neurochemical predictor of motor decision speed
Sumner, P., Edden, R. A. E., Bompas, A., Evans, J., & Singh, K. D. (2010) · Nature Neuroscience · doi:10.1038/nn.2559 · Cited by 162
Neuregulin-1 Modulates Hippocampal Gamma Oscillations: Implications for Schizophrenia
Fisahn, A., Neddens, J., Yan, L., & Buonanno, A. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn107 · Cited by 167
Inan, M., Welagen, J., & Anderson, S. A. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr148 · Cited by 161
Wang, C. Z., Yang, S. F., Xia, Y., & Johnson, K. M. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301647 · Cited by 161
DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
Chen, X.-W., Feng, Y., Hao, C., Guo, X., He, X., Zhou, Z.-Y., Guo, N., Huang, H.-P., Xiong, W., Zheng, H., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711021 · Cited by 166
More Is Less: A Disinhibited Prefrontal Cortex Impairs Cognitive Flexibility
Gruber, A. J., Calhoon, G. G., Shusterman, I., Schoenbaum, G., Roesch, M. R., & O'Donnell, P. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4623-10.2010 · Cited by 160
Behrens, M. M., & B, T. J. S. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.002 · Cited by 163
Kocsis, B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.002 · Cited by 159
GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia
Xu, M., & Wong, A. H. C. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.172 · Cited by 168
Neural basis of psychosis-related behaviour in the infection model of schizophrenia
Meyer, U., & Feldon, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.022 · Cited by 158
Metadata
- Authors
- Lewis, D. A., Hashimoto, T., & Volk, D. W.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Lewis, David A.
- Venue
- Nature Reviews Neuroscience
- Published
- 2005-04
- Volume
- 6
- Issue
- 4
- Pages
- 312-324
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2089912569
- Cited by
- 2,297
- References
- 123
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 63 · 2023: 48 · 2022: 70 · 2021: 86 · 2020: 77 · 2019: 94 · 2018: 102 · 2017: 89 · 2016: 123 · 2015: 148 · 2014: 132 · 2013: 167 · 2012: 151
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, cortical inhibitory neurons, parvalbumin interneurons, GABA synthesis, dorsolateral prefrontal cortex, working memory, perisomatic inhibition, cognitive impairment
- MeSH terms
- Animals, Cerebral Cortex, Humans, Nerve Net, Neural Inhibition, Neurons, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
